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Rocuronium is the anesthetic agent most likely to cause anaphylaxis. Immediately after intravenous rocuronium 
administration, the authors experienced ventilatory impairment due to unilateral bronchospasm (left lung), which 
was relieved by emergency treatment. However, 80 minutes after beginning laparoscopic surgery for rectal cancer, 
the left lung suddenly re-collapsed under pneumoperitoneum in the Trendelenburg position. A postoperative 
intradermal test revealed that rocuronium, vecuronium, atracurium, succinylcholine, or thiopental could induce 
anaphylaxis in this patient, but it was not established whether the second incident during surgery was due to 
endobronchial intubation or anaphylactic bronchospasm. This case cautions that under pneumoperitoneum in the 
Trendelenburg position, patients suspected of being prone to anaphylactic bronchospasm should also be considered 
at risk of endobronchial intubation. (Korean J Anesthesiol 2010; 59: 275-278)
Key Words:  Anaphylaxis, Bronchial spasm, Laparoscopic surgery, Rocuronium.
Recurrent unilateral lung ventilation disorder in a patient 
that experienced rocuronium-induced anaphylactic 
bronchospasm during laparoscopic rectal surgery
-A case report-
Won Joon Choi, Soo Il Choi, Jeong Min Mok, Hyun Soo Kim, and Yun Hong Kim
Department of Anesthesiology and Pain Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 
Seoul, Korea
Received: January 15, 2010.  Revised: 1st, January 27, 2010; 2nd, February 11, 2010.  Accepted: February 23, 2010.
Corresponding author: Yun Hong Kim, M.D., Department of Anesthesiology and Pain Medicine, Kangbuk Samsung Hospital, Sungkyunkwan 
University School of Medicine, 108, Pyeong-dong, Jongno-gu, Seoul 110-746, Korea. Tel: 82-2-2001-2322, Fax: 82-2-2001-2326, E-mail: 
yhkim12@yahoo.co.kr
    This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
CC
    Anaphylaxis is a life-threatening immune reaction mediated 
by IgE. It occurs during anesthesia with a incidence of 1 in 
3,500 to 1 in 13,000 [1]. Rocuronium, is an aminosteroidal 
neuromuscular blocking agent (NMBA), has a structure similar to 
vecuronium and pancuronium, and has recently been reported 
to be the most common causative agent of anaphylaxis [1].
    We experienced two complete failures of ventilation in the 
left lung two during the same operation; one immediately 
after the intravenous administration of rocuronium during 
anesthetic induction and the other during surgery under 
pneumoperitoneum in the Trendelenburg position. Here, we 
report and review the character of anaphylactic attributed to 
rocuronium, and the recurrent collapse of one lung ventilation. 276 www.ekja.org
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    A 52-year-old male, body weight 62 kg, height 161 cm, was 
planned for hand-assisted laparoscopic low anterior resection 
(HAL-LAR) for rectal cancer. There was no history of allergy, 
including asthma, atopy, or drug allergy, either for the patient 
himself or his family. Preoperative antibiotic sensitivity 
testing (AST) was negative for Cefminox. The patient received 
glycopyrrolate 0.2 mg and midazolam 2 mg IM as premedication 
40 min before surgery. Preanesthetic blood pressures (BP) and 
heart rates (HR) were 120/80 mmHg and 65 beats/min (bpm), 
respectively. In the supine position, endotracheal intubation 
was performed 1 minute after the IV administration of 1% 
propofol (Pofol inj, Dongkook Co., Republic of Korea) 12 ml and 
rocuronium (Esmeron
Ⓡ, NV Organon, Netherlands) 50 mg. The 
7.5 mm ID endotracheal tube was secured at 23 cm at upper 
teeth, and equal breathing sounds were noted in both lung fields 
through a stethoscope. Sevoflurane-N2O 2 L/min-O2 2 L/min 
was then delivered for maintenance under volume controlled 
ventilation at a tidal volume (TV) of 600 ml and respiratory rate 
(RR) of 10 rpm, at which the peak inspiratory pressure (PIP) 
was 20 mmHg and end tidal carbon dioxide concentrations 
(EtCO2) were 37-40 mmHg. However, 10 minutes after the 
administration of induction agents, BP suddenly dropped to 
83/53 mmHg at a HR of 145 bpm. Although BP increased to 
93/58 mmHg 15 minutes after induction, capnography showed 
an obstructive pattern with a high PIP (41 mmHg) along with 
skin eruptions within the upper thorax and on both upper 
extremities at the same time (the severities of these were not 
followed after covering the body with surgical wraps during the 
operation). EtCO2 was maintained at 35 mmHg at that time. 
On auscultation, no breathing sound was heard in the left lung 
field and mild wheezing was noted in the right lung. Suctioning 
the airway produced no secretion. We checked for proper tube 
placement by manual cuff palpation at the suprasternal notch, 
and ballottement of the cuff was strongly detected. Accordingly, 
we guessed anaphylactic bronchospasm due to uncertain 
anesthetic agents. Salbutamol sulfate was administered by 
inhalation three times through the endotracheal tube, but 
BP further declined to 75/40 mmHg at a HR of 110 bpm. 
Skin eruptions continued to be observed within the upper 
thorax and both upper extremities. After discontinuing N2O 
and sevoflurane, piprinhydrinate 3 mg and dexamethasone 
5 mg were injected intravenously along with salbutamol 
sulfate administration, but PIP and breathing sounds did not 
improve. Even at TV 300 ml and RR 16 rpm, PIP remained at 
30 mmHg. Although the lowest observed SpO2 value was 95%, 
EtCO2 was maintained at 35 mmHg. Epinephrine 10 μg and 
hydrocortisone 50 mg were then administered intravenously 
twice and three times, respectively. Twenty minutes after the 
onset of symptoms, lung sounds recovered and the capnogram 
normalized with an EtCO2 of 36 mmHg and a PIP of 25 mmHg 
under TV 500 ml and RR 13 rpm, and a BP and HR of 121/66 
mmHg and 97 bpm, respectively. 
    Surgery was performed under carbon dioxide pneumoperi-
toneum at a pressure of 15 mmHg in a 30 degree Trendelenburg 
position under pressure controlled ventilation (PCV) that 
limited the PIP to 27 mmHg, which demonstrated a TV of 
450-500 ml. However, 80 minutes after beginning surgery 
under an inspiratory sevoflurane concentration of 3.6 vol%, 
SpO2 suddenly decreased from 97% to 91% immediate after 
an intravenous injection of furosemide (Lasix
Ⓡ , Handok, 
Republic of Korea) 5 mg. At that time, no auscultation sounds 
were detected in the left lung field under a PIP of 27 mmHg 
during pressure controlled ventilation (PCV) generating a TV 
of only 151 ml. EtCO2 was recorded at this time at 40 mmHg. 
BP decreased to 80/50 mmHg with a HR of 75 bpm. Thus, 
salbutamol sulfate inhalation and intravenous hydrocortisone 
and epinephrine were re-challenged, and the posture changed 
from Trendelenburg to supine. 10 minutes later, SpO2 and BP 
recovered to 96% and 153/94 mmHg, respectively, and both 
lung sounds were fully regained. The surgery was completed 
after colostomy. Total anesthetic duration was 200 minutes. 
The postoperative chest radiograph was normal, and the 
endotracheal tube was extubated 9 hours after completing 
surgery. 
    Patch, skin prick, and intradermal tests (IDT) were carried out 
on postoperative days 8, 15, and 16 to confirm the relationships 
between the patient’s symptoms and anesthetic agents. Several 
types of anesthetics were examined (Table 1). All skin tests were 
performed on the patient’s back. The concentrations of test 
drugs used depended on the type of test. As for the patch test, 
pure commercialized drugs were applied. Skin prick tests were 
Table 1. Results of Anesthetic Skin Reactivity Tests 
Drug Patch test Skin prick test Intradermal test
Rocuronium
Atracurium
Vecuronium
Succinylcholine
Propofol
Thiopental sodium
Glycopyrrolate
Pyridostigmine
Hyperbaric bupivacaine
Lidocaine
Bupivacaine
Latex 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
+
++
++
++
-
+
-
-
-
-
-
-
The results were observed 15 minutes after applying the drugs. +: a 
wheal of 3-5 mm with surrounding erythema of 5-10 mm, ++: a 
wheal >5 mm with erythema of >10 mm. Blank means that the test 
was not performed.  277 www.ekja.org
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performed using solutions of the test drugs, diluted sequentially 
(10
-2 and 10
-1) in 0.9% saline and IDTs were conducted using 
a 10
-1 dilution. Skin test results were graded + when a wheal 
of 3-5 mm with surrounding erythema of 5-10 mm arose 
within 15 minutes after injection, and as ++ when a wheal of 
>5 mm with erythema of >10 mm appeared within 15 minutes. 
It was found that rocuronium, succinylcholine, atracurium, 
vecuronium, and thiopental sodium produced a positive 
reaction only by IDT (Table 1). 
    Surgery to repair the colostomy was carried out 50 days later 
under spinal anesthesia using 0.5% hyperbaric bupivacaine 
15 mg, which had shown no reactivity on previous skin tests. 
The anesthetic duration was 90 minutes and no problem was 
experienced perioperatively. 
Discussion
    The anaphylactic symptoms caused by rocuronium are 
variable, and include; tachycardia, severe hypotension, 
erythematous skin rash, facial or generalized edema, and 
bronchospasm [2,3]. Although anaphylactic symptoms usually 
occur immediately after an allergen challenge, they can be 
delayed for 2-20 minutes [4,5] About 70% of patients that 
experience an anaphylactic bronchospasm have accompanying 
cutaneous signs, such as, a rash or flush [6]. The symptom 
course during induction in our case was very similar to that 
reported for rocuronium-induced anaphylaxis. 
    The clinical aspects of unilateral bronchospasm are similar to 
those of endobronchial intubation [7]. However, endobron  chial 
intubation is also a risk factor of reflex bronchospasm because 
airway instrumentation near the carina, which contains 
abundant irritant receptors, can cause reflex bronchocon-
striction [6]. However, reflex bronchospasm after intubation 
is not accompanied by cutaneous reactions because it does 
not occur via an immune pathway [8]. Propofol can cause 
skin rashes irrespective of anaphylaxis, but for non-immune 
reactions, skin reactions are not associated with cardiovascular 
deteriorations [9]. Accordingly, in our case, it is unlikely that 
the first ventilation disorder was caused by airway irritation, or 
that the skin eruptions were related to propofol induced non-
immune reactions. 
    It has been reported that the mean distance between the 
carina and the endotracheal tube tip in the supine position 
is 3.37 ± 2.21 cm when palpating cuff ballottement at the 
suprasternal notch [10]. Thus, the possibility of endobronchial 
intubation could be excluded by manual cuff palpation at the 
sternal notch in the supine position during the first ventilation 
disorder. Furthermore, a unilateral silent lung accompanied 
by a sudden decrease in BP suggested immune-related 
bronchospasm rather than endobronchial intubation. Thus, 
given this information and the skin test results, we were able to 
strongly associate the first incident with rocuronium-induced 
anaphylactic bronchospasm. Intradermal testing is valuable in 
terms of discerning whether a suspected perioperative allergic 
reaction is caused by IgE-mediated immediate hypersensitivity, 
especially that due to anesthetics [11]. 
    Unilateral bronchospasm usually occurs due to topical 
irritation of the respiratory system [12,13]. However, unilateral 
bronchospasm in our case was triggered by the systemic effects 
of intravenous agents. Tsubo et al. [5] suggested that latex 
allergen, which is absorbed into systemic circulation during 
intra-abdominal gynecological surgery, might induce unilateral 
bronchospasm. Thus, it is possible that anaphylactic antigens 
can induce unilateral bronchospasm not only by topical 
irritation of the involved lung, but also rarely via systemic 
effects. 
    However, contrary to the first bronchospasm, chances were 
that other risk factors might influence on happening of the 
second case of unilateral silent breath sound. The recurrence 
of anaphylactic symptoms is not common after successful 
resuscitation [2,3], and it our case, the Trendelenburg position 
itself is considered unlikely trigger factor because NMBAs-
induced anaphylactic hypotension used to be resuscitated by 
placing patients in the Trendelenburg position. However, it is 
possible that pneumoperitoneum in the Trendelenburg position 
might have induced unilateral endobronchial intubation [14]. 
Furthermore, a zero risk of endobronchial intubation in the 
Trendelenburg position under pneumoperitoneum is not 
guaranteed by confirming tube placement by manual cuff 
palpation in the supine position [14]. However, we did not re-
check the cuff ballottement at the sternal notch after changing 
posture, and thus, it is not clear whether the second incident 
was caused by bronchospasm or a malpositioned tube.
    Moreover, although furosemide is known to be a causative 
agent of anaphylaxis [15], unilateral ventilatory failure was 
unlikely to been related to the administration of furosemide, 
because skin tests were negative. 
    In conclusion, the intravenous administration of rocuronium 
can induce unilateral bronchospasm. Nevertheless, although 
a patient may suffer unilateral bronchospasm due to anaphyl-
axis, it should also be considered that recurrent unilateral 
ven  ti  la  tory failure might be induced during the same surg  ery 
by endobronchial intubation when a patient under pneu-
moperitoneum is in the Trendelenburg position. 
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